| 发明名称 |
Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients |
| 摘要 |
This invention relates to a method for managing the risk of an adverse interaction between teriflunomide and a substrate of breast cancer resistance protein (BCRP) and / or organic anion transporting polypeptide B1 and B3 (OATP1B1/B3). |
| 申请公布号 |
EP2762135(A1) |
申请公布日期 |
2014.08.06 |
| 申请号 |
EP20130305130 |
申请日期 |
2013.02.04 |
| 申请人 |
SANOFI |
发明人 |
|
| 分类号 |
A61K31/277;A61K31/505;A61P25/00 |
主分类号 |
A61K31/277 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
